Mechanisms of immunotherapy resistance in cutaneous melanoma: recognizing a shapeshifter
Melanoma is one of the seven most common cancers in the United States, and its incidence
is still increasing. Since 2011, developments in targeted therapies and immunotherapies …
is still increasing. Since 2011, developments in targeted therapies and immunotherapies …
Identification, culture and targeting of cancer stem cells
A Herreros-Pomares - Life, 2022 - mdpi.com
Chemoresistance, tumor progression, and metastasis are features that are frequently seen
in cancer that have been associated with cancer stem cells (CSCs). These cells are a …
in cancer that have been associated with cancer stem cells (CSCs). These cells are a …
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases—Focus on the Major Histocompatibility Complex (MHC) Antigen Processing …
Interferons (IFNs), divided into type I, type II, and type III IFNs represent proteins that are
secreted from cells in response to various stimuli and provide important information for …
secreted from cells in response to various stimuli and provide important information for …
Role of a Polyphenol-Enriched Blueberry Preparation on Inhibition of Melanoma Cancer Stem Cells and Modulation of MicroRNAs
Melanoma is a type of skin cancer known for its high mortality rate. Cancer stem cells
(CSCs) are a subpopulation of cancer cells that significantly contribute to tumour recurrence …
(CSCs) are a subpopulation of cancer cells that significantly contribute to tumour recurrence …
Targeting cancer stem cells through epigenetic modulation of interferon response
JL Huang, SY Chen, CS Lin - Journal of Personalized Medicine, 2022 - mdpi.com
Cancer stem cells (CSCs) are a small subset of cancer cells and are thought to play a critical
role in the initiation and maintenance of tumor mass. CSCs exhibit similar hallmarks to …
role in the initiation and maintenance of tumor mass. CSCs exhibit similar hallmarks to …
C1ql4 regulates breast cancer cell stemness and epithelial-mesenchymal transition through PI3K/AKT/NF-κB signaling pathway
F Xu, J Wang, S Zhen, Y Duan, Q Li, L Liu - Frontiers in Oncology, 2023 - frontiersin.org
Background The stemness characteristic of breast cancer (BC) is a crucial factor underlying
cancer recurrence and metastasis after operative therapy and chemoradiotherapy …
cancer recurrence and metastasis after operative therapy and chemoradiotherapy …
m7G-Related DNA Damage Repair Genes are Potential Biomarkers for Predicting Prognosis and Immunotherapy Effectiveness in Colon Cancer Patients
S Chen, R Dong, Y Li, N Zheng, G Peng, F Lu… - Frontiers in …, 2022 - frontiersin.org
Objective: m7G is a post-transcriptional modification modality, however, limited research has
been conducted on its role in colon cancer. DNA damage repair (DDR) is an important factor …
been conducted on its role in colon cancer. DNA damage repair (DDR) is an important factor …
[HTML][HTML] Mechanismen der Immuntherapie-Resistenz bei kutanem Melanom: Erkennen eines Formwandlers
Das Melanom ist eine der sieben häufigsten Krebsarten in den USA und seine Häufigkeit
nimmt weiter zu. Seit 2011 haben die Entwicklungen bei zielgerichteten Therapien und …
nimmt weiter zu. Seit 2011 haben die Entwicklungen bei zielgerichteten Therapien und …
GATA2 as an outcome signature: promoting bladder cancer migration and inhibiting PD-L1 expression
S Sun - 2022 - researchsquare.com
Background Embryonic development is regulated by stem cells, and epithelial-to-
mesenchymal transition (EMT) is associated with cell stemness; nevertheless, the EMT …
mesenchymal transition (EMT) is associated with cell stemness; nevertheless, the EMT …
[PDF][PDF] Aus der Klinik und Poliklinik für Geburtshilfe und Frauengesundheit der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
LC Istengir - openscience.ub.uni-mainz.de
CD Chromodomain CDK1 Cyclin-abhängige Kinase 1 CNV Copy number variations CPC
Chromosomal passenger complex CR Complete Remission CSC Cancer stem cells CSD …
Chromosomal passenger complex CR Complete Remission CSC Cancer stem cells CSD …